Search the RE article base
Contact Information
Top 48 Hour View List
Useful Web Sites
Category Archives: History
Pensé and Perspectivability-1
Some of you may have noticed that over the years I have grown more critical of the Bayh-Dole Act and especially of the people who prop it up with various forms of bluffery. The law is based on failed policy … Continue reading
Posted in Bayh-Dole, History, Technology Transfer
Tagged bluffing, experiences, NIPIA, policy, project, research enterprise
Comments Off on Pensé and Perspectivability-1
Peace measures
In 1917, in the United States, six million people suffered from syphilis. The only drug that offered some relief at the time was an arsenic compound made in Germany called salvarsan. The United States entered the first world war against … Continue reading
A century of reaping enormous profits at the expense of sickness and misfortune, 3
The Mayo doctors, having made their specific arguments with regard to salvarsan in their 1917 letter to Congress, end with a full scale plea, not only to cancel the patent for salvarsan but also for other German drugs, and for … Continue reading
A century of reaping enormous profits at the expense of sickness and misfortune, 2
Mayo’s research publication Discovery’s Edge recently ran an article on “The Power of Patents.” In the article, Mayo Clinic wonders about patent royalties from a famous past invention: When Mayo Clinic colleagues Edward Kendall, Ph.D., and Philip Hench, M.D., along with … Continue reading
Posted in History, Policy
Tagged crowd source, monopoly meme, patents, research
Comments Off on A century of reaping enormous profits at the expense of sickness and misfortune, 2
A century of reaping enormous profits at the expense of sickness and misfortune, 1
In June 1917, the United States had just entered the first world war against Germany, and a German chemical maker through its American subsidiary Farbwerke-Hoechst held U.S. patents on salvarsan, a medicine used to treat syphilis. Along letters written on … Continue reading
Hormones and Patents
Graham Dutfield at the University of Leeds has published an article on the development of medical hormone products and patent law, “Patent on Steroids: What Hormones Tell Us about the Evolution of Patent Law.” The article doesn’t do as much … Continue reading
Posted in History, Innovation
Tagged hormones, invention, patents, pharmaceutical
Comments Off on Hormones and Patents
NIST does not understand the government license in Bayh-Dole
NIST has issued a draft green paper that consolidates all the fake history, pseudo data as fact, misrepresentations of Bayh-Dole, and misconceived proposals all in one convenient place. I can’t hope to catch everything, but let’s take a look at … Continue reading
“Government” rights in federally supported inventions, 1
Bayh-Dole requires federal agencies to use a patent rights clause that includes a provision under which contractors who obtain ownership of a patentable invention made in the performance of work under a federal funding agreement and elect to retain that … Continue reading
Posted in Bayh-Dole, History, Policy, Stanford v Roche
Tagged Bayh-Dole, government license, inherent government function, patent rights clause, slop
Comments Off on “Government” rights in federally supported inventions, 1
A clever misrepresentation at the origin of Bayh-Dole
Let’s see if we can isolate the origin of the Bayh-Dole Act. In about four minutes, you will read the following again: The roots, then, of Bayh-Dole are to be found in a mischaracterization of the Harbridge House report of … Continue reading
Posted in Bayh-Dole, History
Tagged 41 CFR 9-1, Bayh-Dole, General Services Administration, monopoly meme
Comments Off on A clever misrepresentation at the origin of Bayh-Dole
28,000 federal patents and the monopoly meme went into a bar, 3
Howard Forman, a long-time patent attorney in the chemical industry turned federal employee, introduced the 28,000 unused federal patents meme into Bayh-Dole rhetoric in his congressional testimony in 1976. Senator Bayh includes Forman’s meme in his introduction of S. 414, … Continue reading